Man who Picked Bitcoin at $428 Says "Buy Genesis"

From Legacy Research | Ad

He Picked Bitcoin (And Dogecoin) in 2016. What He's Recommending Now Could Turn Heads...

Watch more here!

OCUL Insider Trading (Ocular Therapeutix)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.60%

Insider Buying (Last 12 Months): $4,579.76

Insider Selling (Last 12 Months): $143,000.00

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

^$14.45

▲ +0.02 (0.14%)

As of 06/11/2021 01:00 AM ET

Days: 30 | 90 | 365

Warren Buffett Just Poured $15 Billion Into This

From Legacy- BNF Campaigns | Ad

Warren Buffett, Jeff Bezos, and Elon Musk are investing billions in a new trend.

Ocular Therapeutix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/20/2021	Richard L Md Lindstrom	Director	Sell	10,000	$14.30	$143,000.00	90,000
10/16/2020	Summer Road Llc	Major Shareholder	Buy	437	$10.48	$4,579.76
5/19/2020	Summer Road Llc	Major Shareholder	Buy	363,636	$5.50	$1,999,998.00
3/24/2020	Summer Road Llc	Major Shareholder	Buy	109,100	$4.92	$536,772.00
3/19/2020	Summer Road Llc	Major Shareholder	Buy	40,900	$4.63	$189,367.00
3/17/2020	Summer Road Llc	Major Shareholder	Buy	955,062	$5.00	$4,775,310.00
3/13/2020	Summer Road Llc	Major Shareholder	Buy	210,800	$4.63	$976,004.00
1/2/2020	Opaleye Management Inc.	Major Shareholder	Buy	15,000	$4.35	$65,250.00
12/30/2019	Opaleye Management Inc.	Major Shareholder	Buy	20,000	$3.95	$79,000.00
6/14/2019	Donald Notman	CFO	Buy	2,500	$4.33	$10,825.00
6/14/2019	Leslie J Williams	Director	Buy	4,500	$4.40	$19,800.00	4,500
6/7/2019	Amarpreet Sawhney	Chairman	Buy	124,468	$2.92	$363,446.56	990,563
6/6/2019	Antony C Mattessich	CEO	Buy	40,000	$2.81	$112,400.00	97,900
6/5/2019	Amarpreet Sawhney	Chairman	Buy	45,780	$2.91	$133,219.80	898,711
5/28/2019	Michael H Goldstein	Insider	Buy	12,000	$2.51	$30,120.00	25,686
3/15/2019	Jeffrey S Heier	Director	Buy	24,000	$4.15	$99,600.00	24,000
3/15/2019	Michael H. Goldstein	Insider	Buy	10,000	$4.15	$41,500.00
3/13/2019	Richard L Md Lindstrom	Director	Buy	56,441	$4.33	$244,389.53	100,000
12/14/2018	Kevin F Hanley	Insider	Buy	10,000	$5.50	$55,000.00	20,000
12/10/2018	Kevin F Hanley	Insider	Buy	10,000	$5.60	$56,000.00	10,000
12/6/2018	Daniel M Bollag	Insider	Buy	17,400	$5.76	$100,224.00
8/20/2018	Antony C Mattessich	CEO	Buy	20,000	$5.95	$119,000.00	57,900
8/14/2018	Donald Notman	CFO	Buy	12,500	$6.29	$78,625.00	17,300
8/10/2018	Antony C Mattessich	Insider	Buy	16,900	$6.23	$105,287.00	37,900

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

61.90% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/24/2021	Principal Financial Group Inc.	29,529	$0.48M	0.0%	-2.8%	0.039%
5/21/2021	Beacon Investment Advisory Services Inc.	12,000	$0.20M	0.0%	+20.0%	0.016%
5/19/2021	Virtu Financial LLC	15,938	$0.26M	0.0%	N/A	0.021%
5/19/2021	Squarepoint Ops LLC	20,026	$0.33M	0.0%	+94.1%	0.026%
5/18/2021	Millennium Management LLC	194,295	$3.19M	0.0%	N/A	0.255%
5/18/2021	Opaleye Management Inc.	6,480,000	$106.34M	15.6%	-0.5%	8.494%
5/18/2021	D. E. Shaw & Co. Inc.	652,128	$10.70M	0.0%	-37.9%	0.855%
5/18/2021	State of Wisconsin Investment Board	101,800	$1.67M	0.0%	+1.4%	0.133%
5/18/2021	Morgan Stanley	334,326	$5.49M	0.0%	+27.6%	0.438%
5/18/2021	Great Point Partners LLC	1,007,012	$16.53M	3.4%	+17.6%	1.320%
5/18/2021	Dumac Inc.	57,359	$0.94M	1.3%	+52.7%	0.075%
5/18/2021	Gotham Asset Management LLC	24,438	$0.40M	0.0%	-32.3%	0.032%
5/18/2021	Jane Street Group LLC	41,246	$0.68M	0.0%	-21.7%	0.054%
5/18/2021	California State Teachers Retirement System	109,936	$1.80M	0.0%	+6.0%	0.144%
5/17/2021	Endurant Capital Management LP	438,933	$7.20M	1.9%	+51.1%	0.575%
5/17/2021	JS Capital Management LLC	10,500	$0.17M	0.0%	N/A	0.014%
5/17/2021	Kamunting Street Capital Management L.P.	436,307	$7.16M	2.8%	+527.8%	0.572%
5/17/2021	Fred Alger Management LLC	70,477	$1.16M	0.0%	-1.4%	0.092%
5/17/2021	AQR Capital Management LLC	65,077	$1.07M	0.0%	+33.4%	0.085%
5/17/2021	Royal Bank of Canada	79,702	$1.31M	0.0%	-7.1%	0.104%
5/17/2021	Price T Rowe Associates Inc. MD	32,901	$0.54M	0.0%	+26.9%	0.043%
5/17/2021	Ameriprise Financial Inc.	11,290	$0.19M	0.0%	-11.4%	0.015%
5/17/2021	Nuveen Asset Management LLC	254,951	$4.18M	0.0%	-57.6%	0.334%
5/17/2021	Goldman Sachs Group Inc.	637,749	$10.47M	0.0%	+26.2%	0.836%
5/14/2021	Brown Advisory Inc.	90,000	$1.48M	0.0%	N/A	0.118%
5/14/2021	Castleark Management LLC	485,837	$7.97M	0.3%	+48.7%	0.637%
5/14/2021	Rubric Capital Management LP	382,386	$6.28M	0.4%	N/A	0.501%
5/14/2021	UBS Asset Management Americas Inc.	62,448	$1.03M	0.0%	+24.6%	0.082%
5/14/2021	Dynamic Technology Lab Private Ltd	20,828	$0.34M	0.0%	N/A	0.027%
5/14/2021	Credit Suisse AG	42,797	$0.70M	0.0%	-34.1%	0.056%
5/13/2021	Trexquant Investment LP	31,263	$0.51M	0.0%	N/A	0.041%
5/13/2021	SG Americas Securities LLC	15,072	$0.25M	0.0%	+39.8%	0.020%
5/13/2021	Barclays PLC	65,631	$1.08M	0.0%	+192.6%	0.086%
5/13/2021	Renaissance Technologies LLC	49,900	$0.82M	0.0%	-85.1%	0.065%
5/13/2021	Neuberger Berman Group LLC	61,539	$1.01M	0.0%	-3.2%	0.081%
5/13/2021	Alpine Global Management LLC	10,876	$0.18M	0.0%	N/A	0.014%
5/13/2021	Bank of New York Mellon Corp	257,917	$4.23M	0.0%	-20.2%	0.338%
5/13/2021	Citigroup Inc.	14,173	$0.23M	0.0%	-34.0%	0.019%
5/13/2021	Federated Hermes Inc.	313,238	$5.14M	0.0%	+25.8%	0.411%
5/13/2021	Bank of Montreal Can	3,397	$56K	0.0%	-70.9%	0.004%
5/12/2021	Northern Trust Corp	788,944	$12.95M	0.0%	+0.9%	1.034%
5/12/2021	Ergoteles LLC	51,726	$0.85M	0.0%	N/A	0.068%
5/12/2021	Geode Capital Management LLC	1,229,608	$20.18M	0.0%	+12.8%	1.612%
5/12/2021	Lisanti Capital Growth LLC	194,800	$3.20M	0.4%	-46.8%	0.255%
5/12/2021	Ensign Peak Advisors Inc	59,711	$0.98M	0.0%	+198.6%	0.078%
5/12/2021	JPMorgan Chase & Co.	40,304	$0.66M	0.0%	-50.8%	0.053%
5/12/2021	Sei Investments Co.	75,250	$1.48M	0.0%	+34.1%	0.099%
5/12/2021	UBS Group AG	550,864	$9.04M	0.0%	-11.2%	0.722%
5/10/2021	Nottingham Advisors Inc.	194,266	$3.19M	0.4%	-0.8%	0.255%
5/10/2021	HighTower Advisors LLC	11,284	$0.19M	0.0%	-10.9%	0.015%
5/10/2021	Principal Financial Group Inc.	29,529	$0.48M	0.0%	-2.8%	0.039%
5/10/2021	Shell Asset Management Co.	7,263	$0.12M	0.0%	N/A	0.010%
5/7/2021	BlackRock Inc.	5,867,062	$96.28M	0.0%	+6.4%	7.713%
5/7/2021	American International Group Inc.	42,479	$0.70M	0.0%	+6.5%	0.056%
5/7/2021	BNP Paribas Arbitrage SA	9,563	$0.16M	0.0%	-28.5%	0.013%
5/7/2021	Swiss National Bank	138,600	$2.27M	0.0%	+1.1%	0.182%
5/6/2021	Rhumbline Advisers	83,526	$1.37M	0.0%	-2.6%	0.110%
5/6/2021	Alliancebernstein L.P.	86,600	$1.42M	0.0%	+2.6%	0.114%
5/6/2021	Altium Capital Management LP	326,174	$5.31M	1.5%	+7.6%	0.429%
5/4/2021	Victory Capital Management Inc.	1,548,627	$25.41M	0.0%	+42.5%	2.036%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	10,665	$0.18M	0.0%	+7.3%	0.014%
4/30/2021	Creative Planning	26,083	$0.43M	0.0%	+10.5%	0.034%
4/29/2021	Vigilare Wealth Management	23,160	$0.38M	0.3%	+71.2%	0.030%
4/29/2021	Emerald Mutual Fund Advisers Trust	1,353,896	$22.22M	0.7%	+20.7%	1.780%
4/29/2021	Emerald Advisers LLC	1,294,850	$21.25M	0.8%	+8.7%	1.702%
4/28/2021	Spearhead Capital Advisors LLC	20,281	$0.33M	0.0%	N/A	0.027%
4/28/2021	Lindbrook Capital LLC	7,200	$0.12M	0.0%	+92.1%	0.009%
4/26/2021	GWM Advisors LLC	13,780	$0.23M	0.0%	-28.1%	0.018%
4/21/2021	Deltec Asset Management LLC	2,096,341	$34.40M	5.1%	-3.3%	2.756%
3/16/2021	Dumac Inc.	37,567	$0.78M	0.6%	N/A	0.050%
3/12/2021	DekaBank Deutsche Girozentrale	22,900	$0.45M	0.0%	N/A	0.030%
3/10/2021	Los Angeles Capital Management LLC	13,410	$0.28M	0.0%	N/A	0.018%
3/1/2021	UBS Asset Management Americas Inc.	50,137	$1.04M	0.0%	N/A	0.066%
2/23/2021	Principal Financial Group Inc.	30,365	$0.63M	0.0%	N/A	0.040%
2/19/2021	JPMorgan Chase & Co.	81,880	$1.70M	0.0%	-64.1%	0.108%
2/17/2021	Voloridge Investment Management LLC	24,060	$0.50M	0.0%	N/A	0.032%
2/17/2021	Castleark Management LLC	326,642	$6.76M	0.3%	N/A	0.431%
2/16/2021	Squarepoint Ops LLC	10,315	$0.21M	0.0%	-91.2%	0.014%
2/16/2021	Morgan Stanley	261,917	$5.42M	0.0%	-1.0%	0.345%
2/16/2021	Endurant Capital Management LP	290,465	$6.01M	2.2%	-65.3%	0.383%
2/16/2021	Nuveen Asset Management LLC	600,671	$12.43M	0.0%	+143.5%	0.792%
2/16/2021	Price T Rowe Associates Inc. MD	25,928	$0.54M	0.0%	N/A	0.034%
2/16/2021	ETF Managers Group LLC	59,796	$1.22M	0.0%	N/A	0.079%
2/16/2021	Engineers Gate Manager LP	32,991	$0.68M	0.0%	N/A	0.043%
2/16/2021	Avidity Partners Management LP	250,000	$5.18M	0.2%	N/A	0.330%
2/16/2021	Charles Schwab Investment Management Inc.	168,640	$3.49M	0.0%	+14.3%	0.222%
2/13/2021	American International Group Inc.	39,872	$0.83M	0.0%	+10.2%	0.053%
2/12/2021	Opaleye Management Inc.	6,510,000	$134.76M	17.6%	+8.8%	8.581%
2/12/2021	Penserra Capital Management LLC	1,640	$33K	0.0%	N/A	0.002%
2/12/2021	Federated Hermes Inc.	248,911	$5.15M	0.0%	+118,996.2%	0.328%
2/12/2021	Raymond James Financial Services Advisors Inc.	24,890	$0.52M	0.0%	+18.4%	0.033%
2/12/2021	Amalgamated Bank	10,662	$0.22M	0.0%	N/A	0.014%
2/12/2021	The Manufacturers Life Insurance Company	40,819	$0.85M	0.0%	+18.2%	0.054%
2/12/2021	Credit Suisse AG	64,955	$1.34M	0.0%	N/A	0.086%
2/11/2021	Northern Trust Corp	781,570	$16.18M	0.0%	+14.6%	1.030%
2/11/2021	Barclays PLC	22,428	$0.46M	0.0%	-26.3%	0.030%
2/11/2021	Citigroup Inc.	21,483	$0.45M	0.0%	-3.2%	0.028%
2/11/2021	Monashee Investment Management LLC	60,000	$1.24M	0.2%	N/A	0.079%
2/10/2021	Rhumbline Advisers	85,715	$1.77M	0.0%	+21.2%	0.113%
2/10/2021	Renaissance Technologies LLC	334,066	$6.92M	0.0%	N/A	0.440%

Data available starting January 2016

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant administered by the fine-gauge needle that is in phase 1 clinical trial for the treatment of wet age-related macular degeneration; OTX-TIC, a travoprost intracameral implant, which is in phase 1 clinical trial for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that is in phase 2 clinical trial for the chronic treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trial for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company is involved in the development of OTX-AFS, an aflibercept suprachoroidal injection for the treatment of retinal diseases. It has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $14.45

$14.10

$14.54

50 Day Range

MA: $15.47

$13.75

$19.16

52 Week Range

Now: $14.45

$7.14

$24.30

Volume

450,023 shs

Average Volume

1,045,927 shs

Market Capitalization

$1.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Who are the company insiders with the largest holdings of Ocular Therapeutix?

Ocular Therapeutix's top insider investors include:

Richard L Md Lindstrom (Director)
Leslie J Williams (Director)
Donald Notman (CFO)
Opaleye Management Inc (Major Shareholder)
Summer Road Llc (Major Shareholder)

Who are the major institutional investors of Ocular Therapeutix?

Ocular Therapeutix's top institutional investors include:

Opaleye Management Inc. — 8.49%
BlackRock Inc. — 7.71%
Deltec Asset Management LLC — 2.76%
Victory Capital Management Inc. — 2.04%
Emerald Mutual Fund Advisers Trust — 1.78%
Emerald Advisers LLC — 1.70%

Which major investors are selling Ocular Therapeutix stock?

In the previous quarter, OCUL stock was sold by these institutional investors:

D. E. Shaw & Co. Inc.
Nuveen Asset Management LLC
Renaissance Technologies LLC
Lisanti Capital Growth LLC
Deltec Asset Management LLC
UBS Group AG
Bank of New York Mellon Corp
JPMorgan Chase & Co.

Which major investors are buying Ocular Therapeutix stock?

In the previous quarter, OCUL stock was purchased by institutional investors including:

Victory Capital Management Inc.
Rubric Capital Management LP
Kamunting Street Capital Management L.P.
BlackRock Inc.
Emerald Mutual Fund Advisers Trust
Millennium Management LLC
Castleark Management LLC
Great Point Partners LLC

During the previous year, these company insiders have bought Ocular Therapeutix stock:

Richard L Md Lindstrom (Director)
Leslie J Williams (Director)
Donald Notman (CFO)
Opaleye Management Inc (Major Shareholder)

Man Who Picked Tesla, Bitcoin Makes Next “Pick of the Decade"

From Legacy Research | Ad

Picking the right “investment of the decade” can transform your life…

Today, the Wall Street legend who picked the last “investment of the decade”… months (even years) before his peers… will finally reveal his new #1 pick for the 2020s.

It’s not 5G, artificial intelligence, EVs, or clean energy. The answer will surprise you.

Click To See This #1 Pick.